Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1994;23:613-618

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, T. L.
Right arrow Articles by Burnett, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, T. L.
Right arrow Articles by Burnett, J. C., Jr
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Hypertension, Vol 23, 613-618, Copyright © 1994 by American Heart Association


ARTICLES

Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor

TL Stevens, CM Wei, LL Aahrus, DM Heublein, M Kinoshita, Y Matsuda and JC Burnett Jr
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minn 55905.

Atrial natriuretic peptide is an important peptide hormone of cardiac origin that functions to regulate cardiac preload via the regulation of sodium excretion. This natriuretic action occurs through activation of the particulate guanylyl cyclase-linked natriuretic peptide-A receptor. HS-142-1 is a newly discovered antagonist of the natriuretic peptide-A receptor that permits insight into the functional role of atrial natriuretic peptide in cardiorenal homeostasis. The first objective of this study was to define for the first time the intrarenal action of HS- 142-1 on exogenous atrial natriuretic peptide-mediated natriuresis in anesthetized normal dogs. In group 1 (n = 6), which received intravenous atrial natriuretic peptide at 100 ng/kg per minute, intrarenal HS-142-1 (0.5 mg/kg bolus) attenuated atrial natriuretic peptide-induced increases in glomerular filtration rate, urine flow, sodium excretion, and renal cyclic GMP generation and decreases in distal tubular sodium reabsorption. The second objective was to determine whether endogenous atrial natriuretic peptide participates in the regulation of basal sodium excretion. In group 2 (n = 6), intrarenal HS-142-1 alone decreased both absolute and fractional sodium excretion and renal cyclic GMP generation and increased distal tubular sodium reabsorption. These studies demonstrate that HS-142-1 markedly attenuates exogenous atrial natriuretic peptide-mediated natriuresis via enhancement of distal tubular reabsorption and blunting of increases in glomerular filtration rate. Second, the current studies support a functional role for endogenous atrial natriuretic peptide in the regulation of basal sodium excretion.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. L. Martin, T. Supaporn, H. H. Chen, S. M. Sandberg, Y. Matsuda, M. Jougasaki, and J. C. Burnett Jr.
Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1580 - R1585.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Boomsma and A. H. van den Meiracker
Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use
Cardiovasc Res, August 15, 2001; 51(3): 442 - 449.
[Full Text] [PDF]


Home page
CirculationHome page
O. Lisy, M. M. Redfield, S. Jovanovic, M. Jougasaki, A. Jovanovic, H. Leskinen, A. Terzic, and J. C. Burnett Jr
Mechanical Unloading Versus Neurohumoral Stimulation on Myocardial Structure and Endocrine Function In Vivo
Circulation, July 18, 2000; 102(3): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. WILLENBROCK, I. PAGEL, M. SCHEUERMANN, K. HÖHNEL, H. S. MACKENZIE, B. M. BRENNER, and R. DIETZ
Renal Function in High-Output Heart Failure in Rats: Role ofEndogenous Natriuretic Peptides
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 572 - 580.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Yamamoto, J. C. Burnett Jr., and M. M. Redfield
Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart
Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2406 - H2414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Gunning, R. J. Solomon, F. H. Epstein, and P. Silva
Role of guanylyl cyclase receptors for CNP in salt secretion by shark rectal gland
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1400 - R1406.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Marttila, O. Vuolteenaho, D. Ganten, K. Nakao, and H. Ruskoaho
Synthesis and Secretion of Natriuretic Peptides in the Hypertensive TGR(mREN-2)27 Transgenic Rat
Hypertension, December 1, 1996; 28(6): 995 - 1004.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. G. Drewett, B. M. Fendly, D. L. Garbers, and D. G. Lowe
Natriuretic Peptide Receptor-B (Guanylyl Cyclase-B) Mediates C-type Natriuretic Peptide Relaxation of Precontracted Rat Aorta
J. Biol. Chem., March 3, 1995; 270(9): 4668 - 4674.
[Abstract] [Full Text] [PDF]